USD87.45EUR95.88RUB1.07
24.kg

Sanofi returns to Kyrgyzstan: Agreement reached in France on drug supplies

11:26, 21 May 2026, Bishkek - 24.kg news agency
Anastasia BENGARD

During a working visit to France, Kyrgyzstan’s Minister of Health, Damir Osmonov, held talks with representatives of Sanofi, one of the world’s largest pharmaceutical companies. Thibaud Lefort, Head of Operations at Sanofi Global Health, participated in the meeting.

According to the Ministry of Health’s press center, during the talks, the parties discussed expanding the population’s access to high-quality, evidence-based, internationally recognized medicines. Providing patients with modern and safe medications is one of the country’s healthcare system’s priorities.

«It is extremely important to us that citizens of Kyrgyzstan have access to high-quality medicines that meet international standards. Cooperation with global companies such as Sanofi opens up new opportunities for patients and the entire healthcare system,» Damir Osmonov noted.

Following the meeting, the parties discussed the possibility of establishing direct drug supplies to the Kyrgyz Republic through the state-owned enterprise Kyrgyzfamatsiya. It is expected that such a mechanism will reduce the number of intermediaries, increase the availability of medicines, and create conditions for more favorable drug prices for the country.

Special attention was paid to the development of telemedicine. The French side is ready to consider cooperation on the implementation of digital solutions that will strengthen the connection between medical facilities in remote areas and leading clinics in Bishkek and regional centers. This is particularly important for improving access to specialized medical care in the regions.

In addition, the prospects for digitizing drug procurement processes and increasing the transparency of the state-owned enterprise Kyrgyzfarmatsiya were discussed. The discussion focused on the possible implementation of modern IT solutions to improve the system for managing and monitoring drug supplies.

In recent years, there has been discussion in Kyrgyzstan’s pharmaceutical market regarding the reduced presence of several international companies, including Sanofi products. However, the current negotiations have demonstrated the French side’s interest in resuming and expanding cooperation with the Kyrgyz Republic.

  • Sanofi is one of the leading international pharmaceutical companies, producing drugs for the treatment of diabetes, cardiovascular, oncological, rare, and immunological diseases, as well as vaccines and innovative medicines.

CONTACTS

SOCIAL MEDIA

TelegramYouTubeWhatsAppFacebookInstagram

© News Agency «24.kg» - News of Kyrgyzstan. All rights reserved. All information posted on this website is intended for personal use only and may not be distributed without the written permission of NA «24.kg». The editorial team is not responsible for the content of reprinted materials and statements of individuals. +18